IMPACT BIOMEDICAL INC. amended Amendment No. 1 to the Merger and Share Exchange Agreement with Dr Ashleys Limited, Dr Ashleys Nevada Sub, Inc., Dr Ashleys Bio Labs Limited, Kanans Visvanats (effective 2026-02-27).
“On February 27, 2026, the parties entered into Amendment No. 1 to the Merger and Share Exchange Agreement (the “Amendment to the Original Merger and Share Exchange Agreement” and, together with the Original Merger and Share Exchange Agreement, the “Merger and Share Exchange Agreement”).”
Chan Heng Fai Ambrose was appointed as Director at IMPACT BIOMEDICAL INC..
“On March 11, 2025, the Board of Directors of the Company appointed Mr. Chan Heng Fai Ambrose to serve as a Director of the Company, effective as of the same date.”
Jason T. Grady was appointed as Director at IMPACT BIOMEDICAL INC..
“Additionally on June 6, 2024, the Board of Directors of the Company appointed Jason T. Grady to serve as a Director of the Company, effective as of the same date.”
Heng Fai Ambrose Chan resigned as Director at IMPACT BIOMEDICAL INC..
“On June 6, 2024, Heng Fai Ambrose Chan notified Impact Biomedical, Inc. (the “Company”) that he is resigning as a member of the Board of Directors of the Company, effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.